Loading insider details...
Beta
Latest Form 4 (Aug 7, 2026): Sale of 3,564 ATRC shares, $138.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 7, 2026 | AtriCure, Inc. (ATRC) | Sale | 3,564 | $138.3K |
| Jun 5, 2026 | Outset Medical, Inc. (OM) | Grant/Award | 10,667 | n/a |
| May 22, 2026 | AtriCure, Inc. (ATRC) | Sale | 3,000 | $86.0K |
| May 20, 2026 | AtriCure, Inc. (ATRC) | Grant/Award | 6,144 | n/a |
| Feb 13, 2026 | Embecta Corp. (EMBC) | Grant/Award | 22,841 | n/a |
| Jan 12, 2026 | Outset Medical, Inc. (OM) | Grant/Award | 18,667 | n/a |
| May 21, 2025 | AtriCure, Inc. (ATRC) | Grant/Award | 5,401 | n/a |
| Mar 7, 2025 | AtriCure, Inc. (ATRC) | Sale | 6,100 | $232.5K |
| Feb 14, 2025 | Embecta Corp. (EMBC) | Grant/Award | 13,839 | n/a |
| May 28, 2024 | NEVRO CORP (NVRO) | Grant/Award | 19,169 | n/a |